Significant upgrades to GPT-Rosalind, its specialized AI model for life sciences. The update adds enhanced biological reasoning, medicinal chemistry expertise, genomics analysis, and experimental workflow capabilities.
The model is designed to assist researchers in drug discovery, protein analysis, and interpreting complex biological data. GPT-Rosalind can now reason across multiple layers of biological systems and suggest experimental designs.
These capabilities build on OpenAI broader push into scientific AI, following the recent launch of Rosalind Biodefense for vetted developers and government partners working on biodefense and pandemic preparedness.